alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.2


 


Mr. Thomas M. Good


c/o First Busey Corporation


100 West University


Champaign, Illinois  61824-4028


 


Dear Tom:


 


As you are aware, First Busey Corporation has
implemented several changes in the executive management of the company.  As part of this management restructuring, on
or about March 31, 2010, your position will change from Executive Vice
President, Risk Management to Executive Vice President and Senior Business
Lender of the Busey West Region.


 


In this new position you will report to the Executive
Vice President, Business Banking of Busey Bank. 
Your compensation and benefits will remain unchanged at this time, but
may change when all management compensation is reviewed after the end of the
first quarter of this year.  You will
continue to perform other responsibilities assigned by the Chief Executive
Officer or the board of directors.


 


Please confirm your acquiescence and agreement to the
changes noted above as though such changes were reflected in your employment
agreement with First Busey by signing below and returning a copy of this letter
to Dave White.  This letter will act as
an addendum to your employment agreement.


 


Thank you for your continued efforts.


 


	
   

  	
  Very truly yours,

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Van A. Dukeman

  
	
   

  	
  President and CEO

  
	
   

  	
  First Busey Corporation

  



 


 


I understand and agree to the foregoing changes to my
job title and related job duties and responsibilities.


 


 


	
  /s/ Thomas M. Good

  	
   

  
	
  Thomas M. Good
1/21/2015

FEIST, HERBERT HERMAN

OFFICIAL NOTICE FROM COURT OF CRIMINAL APPEALS OF TEXAS

P.O. BOX 12308, CAPITOL STATION, AUSTIN, TEXAS 78711

OFFICIAL BUSINESS ,^-.r ^P°s^

STATE OF TEXAS ./CilS

FEWALTYFOIR

Tr.Ct. No. 39295-M

On this day, the application for 11.07 Writ, of Habeas Corpus has been received

and presented to the Court. '""' .,

Abel Acosta, Clerk

HERBERT HERMAN FEIST

JEFFERSON COUNTY CORRECTIONAL FACILITY -

TDC# UTF

P. O. BOX 26007

BEAUMONT, TX 77720

".-'- •' "" • '• •'•'.'•'V:': '••' •'.•'•'••'•••''::.'•••: ' ••' : .-••'.•/•..:.

JAN27 2015 ,

MAILEDFROM ZIPCODF 7S7fi-, >• WR-12,375-21

:TN3B 77720 iII,i)'|i.|,..|.»qM|j.|mf.j,iii,il,|.i||,,7,if|,..|.,,,j,li|/

•C
[Federal Register Volume 60, Number 74 (Tuesday, April 18, 1995)]
[Notices]
[Pages 19405-19406]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-9473]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration 
(SAMHSA); Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given of the 
meeting of the Substance Abuse and Mental Health Services 
Administration (SAMHSA) National Advisory Council on May 15, 1995. 
[[Page 19406]] 
    A portion of the meeting of the SAMHSA National Advisory Council 
will be open and will include a discussion of SAMHSA's reauthorization 
and budget issues, the SAMHSA strategic plan and managed care 
activities within the Agency. In addition, there will be status reports 
by the Council's workgroups on Health Care Reform, AIDS, Program 
Evaluation, and Co-Occurring Mental Illness and Substance Use 
Disorders. Attendance by the public will be limited to space available.
    The meeting will also include the review, discussion and evaluation 
of contract proposals. Therefore, a portion of the meeting will be 
closed to the public as determined by the Administrator, SAMHSA, in 
accordance with 5 U.S.C. 552b(c) (3), (4) and (6) and 5 U.S.C. app. 2 
10(d).
    A summary of the meeting and a roster of council members may be 
obtained from: Ms. Susan E. Day, Program Assistant, SAMHSA National 
Advisory Council, 5600 Fishers Lane, Room 12C-15, Rockville, Maryland 
20857. Telephone: (301) 443-4640.
    Substantive program information may be obtained from the contact 
whose name and telephone number is listed below.

    Committee name: Substance Abuse and Mental Health Services 
Administration, National Advisory Council.
    Meeting date: May 15, 1995.
    Place: Chevy Chase Holiday Inn, Palladian-East Room, 5520 
Wisconsin Avenue, Chevy Chase, Maryland.
    Open: May 15, 1995, 9 a.m. to 3 p.m.
    Closed: May 15, 1995, 3:15 p.m. to 6:30 p.m.
    Contact: Toian Vaughn, Room 12C-15, Parklawn Building, Telephone 
(301) 443-4640.

    Dated: April 12, 1995.
Jeri Lipov,
Committee Management Officer, SAMHSA.
[FR Doc. 95-9473 Filed 4-17-95; 8:45 am]
BILLING CODE 4162-20-P
**Exhibit 31(a)****CERTIFICATIONS****CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER**I, Michael J. Quillen, certify that:1. I have reviewed this quarterly report on Form 10-Q (this “Report”) of Alpha NaturalResources, Inc. (the “Registrant”); 2. Based on my knowledge, this Report does not contain any untrue statement of a materialfact or omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to theperiod covered by this Report; 3. Based on my knowledge, the financial statements, and other financial information includedin this Report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the Registrant as of, and for, the periods presented in thisReport; 4. The Registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)and 15d-15(e)) for the Registrant and have: a. Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure that materialinformation relating to the Registrant, including its consolidated subsidiaries, is madeknown to us by others within those entities, particularly during the period in which thisReport is being prepared;  b. Evaluated the effectiveness of the Registrant’s disclosure controls and procedures andpresented in this Report our conclusions about the effectiveness of the disclosure controlsand procedures, as of the end of the period covered by this Report based on such evaluation;and  c. Disclosed in this Report any change in the Registrant’s internal control over financialreporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’sfourth fiscal quarter in the case of an annual report) that has materially affected, or isreasonably likely to materially affect, the Registrant’s internal control over financialreporting;5. The Registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the Registrant’s auditors andthe audit committee of the Registrant’s board of directors (or persons performing theequivalent functions): a. All significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affectthe Registrant’s ability to record, process, summarize and report financial information;and  b. Any fraud, whether or not material, that involves management or other employees who havea significant role in the Registrant’s internal control over financial reporting.        /s/ Michael J. Quillen          Michael J. Quillen      *President and Chief Executive Officer*      *(Principal Executive Officer)*  Date: November 14, 2005
11TH COURT OF APPEALS

EASTLAND, TEXAS

JUDGMENT

Harold Wayne Mitchell, * From the 238th District Court

 Of Midland County,

Trial Court No. CR43869.

Vs. No. 11-15-00065-CR * April 23, 2015

The State of Texas, * Per Curiam Memorandum Opinion

 (Panel consists of: Wright, C.J.,

 Willson, J., and Bailey, J.)

 This court has inspected the record in this cause and concludes that the appeal 

should be dismissed for want of jurisdiction. Therefore, in accordance with this 

court’s opinion, the appeal is dismissed.
**EXHIBIT
      32.1**




CERTIFICATIONS
      PURSUANT TO


18
      U.S.C.
      SECTION 1350,


AS
      ADOPTED PURSUANT TO


SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002




In
      connection with the accompanying Quarterly Report of Lightspace Corporation
      (the
“Company”) on Form 10-Q (the “Report”) for the quarter ending September 30, 2008
      as filed with the Securities and Exchange Commission on the date hereof, I,
      Gary
      Florindo, Chief Executive Officer and Chief Financial Officer of the Company,
      certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
      906
      of the Sarbanes-Oxley Act of 2002, that to the best of my
      knowledge:




(1)
      The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and




(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.




/s/Gary
                FlorindoGary
                FlorindoChief
                Executive Officer
              and
                Chief Financial
              Officer




November
      12, 2008
[Federal Register Volume 86, Number 108 (Tuesday, June 8, 2021)]
[Notices]
[Pages 30517-30531]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11897]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY

Office of Foreign Assets Control


Notice of OFAC Sanctions Actions

AGENCY: Office of Foreign Assets Control, Treasury.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The U.S. Department of the Treasury's Office of Foreign Assets 
Control (OFAC) is publishing the names of one or more persons that have 
been placed on OFAC's Specially Designated Nationals and Blocked 
Persons List (SDN List) based on OFAC's determination that one or more 
applicable legal criteria were satisfied. All property and interests in 
property subject to U.S. jurisdiction of these persons are blocked, and 
U.S. persons are generally prohibited from engaging in transactions 
with them.

DATES: See Supplementary Information section for effective date(s).

FOR FURTHER INFORMATION CONTACT: OFAC: Andrea Gacki, Director, tel.: 
202-622-2490; Associate Director for Global Targeting, tel.: 202-622-
2420; Assistant Director for Licensing, tel.: 202-622-2480; Assistant 
Director for Regulatory Affairs, tel.: 202-622-4855; or the Assistant 
Director for Sanctions Compliance & Evaluation, tel.: 202-622-2490.

SUPPLEMENTARY INFORMATION:

Electronic Availability

    The Specially Designated Nationals and Blocked Persons List and 
additional

[[Page 30518]]

information concerning OFAC sanctions programs are available on OFAC's 
website (https://www.treasury.gov/ofac).

Notice of OFAC Action(s)

    On June 2, 2021, OFAC determined that the property and interests in 
property subject to U.S. jurisdiction of the following persons are 
blocked under the relevant sanctions authorities listed below.
BILLING CODE 4810-AL-P
[GRAPHIC] [TIFF OMITTED] TN08JN21.000


[[Page 30519]]


[GRAPHIC] [TIFF OMITTED] TN08JN21.001


[[Page 30520]]


[GRAPHIC] [TIFF OMITTED] TN08JN21.002


[[Page 30521]]


[GRAPHIC] [TIFF OMITTED] TN08JN21.003


[[Page 30522]]


[GRAPHIC] [TIFF OMITTED] TN08JN21.004


[[Page 30523]]


[GRAPHIC] [TIFF OMITTED] TN08JN21.005


[[Page 30524]]


[GRAPHIC] [TIFF OMITTED] TN08JN21.006


[[Page 30525]]


[GRAPHIC] [TIFF OMITTED] TN08JN21.007


[[Page 30526]]


[GRAPHIC] [TIFF OMITTED] TN08JN21.008


[[Page 30527]]


[GRAPHIC] [TIFF OMITTED] TN08JN21.009


[[Page 30528]]


[GRAPHIC] [TIFF OMITTED] TN08JN21.010


[[Page 30529]]


[GRAPHIC] [TIFF OMITTED] TN08JN21.011


[[Page 30530]]


[GRAPHIC] [TIFF OMITTED] TN08JN21.012


[[Page 30531]]


[GRAPHIC] [TIFF OMITTED] TN08JN21.013


    Dated: June 2, 2021.
Bradley T. Smith,
Acting Director, Office of Foreign Assets Control.
[FR Doc. 2021-11897 Filed 6-7-21; 8:45 am]
BILLING CODE 4810-AL-C
[Federal Register Volume 60, Number 76 (Thursday, April 20, 1995)]
[Notices]
[Pages 19778-19779]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-9803]



-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE
Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Affymetrix, Inc./Molecular Dynamics, Inc.

    Notice is hereby given that, on January 17, 1995, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), [[Page 19779]] Affymetrix, 
Inc. and Molecular Dynamics, Inc. have filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing (1) the identities of the parties and (2) the 
nature and objectives of the venture. The notifications were filed for 
the purpose of invoking the Act's provisions limiting the recovery of 
antitrust plaintiffs to actual damages under specified circumstances. 
Pursuant to Section 6(b) of the Act, the identities of the parties are: 
Affymetrix, Inc., Santa Clara, CA; and Molecular Dynamics, Inc., 
Sunnyvale, CA. The research and development activities relate to 
miniaturized integrated nucleic acid diagnostic (MIND<SUP>TM) 
development.
Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 95-9803 Filed 4-19-95; 8:45 am]
BILLING CODE 4410--01-M
ex46.htm







FORM OF


NOMINEE HOLDER CERTIFICATION


 



The undersigned, a bank, broker, trustee, depositary or other nominee of non-transferable, non-tradable rights (the “Rights”) to purchase shares of common stock, par value $0.001 per share, of Xfone, Inc. (the “Company”) pursuant to the rights offering described and provided for in the Company’s Prospectus dated [●], 2011 (the “Prospectus”), hereby certifies to the Company and to Transfer Online, Inc. as U.S. Subscription Agent for such rights offering, that (1) the undersigned has exercised, on behalf of the beneficial owners thereof (which may include the undersigned), the number of Rights specified below pursuant to the Basic Subscription Privilege (as defined in the Prospectus) and, on behalf of beneficial owners of Rights who have subscribed for the purchase of additional shares of common stock pursuant to the Oversubscription Privilege (as defined in the Prospectus), the number of shares specified below pursuant to the Oversubscription Privilege, listing separately below each such exercised Basic Subscription Privilege and the corresponding Oversubscription Privilege (without identifying any such beneficial owner), and (2) to the extent a beneficial owner has elected to subscribe for shares pursuant to the Oversubscription Privilege, each such beneficial owner’s Basic Subscription Privilege has been exercised in full:








	
Number of Shares Owned on


the Record Date

	  	
Number of Shares Subscribed


for Pursuant to Basic


Subscription Privilege

	  	
Number of Shares Subscribed


for Pursuant to


Oversubscription Privilege


	  	  	  	  	  
	
1.

	  	  	  	  	  
	  	  	  	  	  
	
2.

	  	  	  	  	  
	  	  	  	  	  
	
3.

	  	  	  	  	  
	  	  	  	  	  
	
4.

	  	  	  	  	  
	  	  	  	  	  
	
5.

	  	  	  	  	  
	  	  	  	  	  
	
6.

	  	  	  	  	  
	  	  	  	  	  
	
7.

	  	  	  	  	  
	  	  	  	  	  
	
8.

	  	  	  	  	  
	  	  	  	  	  
	
9.

	  	  	  	  	  










Provide the following information if applicable:







____________________________________________


Depository & Trust Clearing Corporation (“DTC”)


Participant Number







Participant Printed Name:  _____________________________________________








	
By: 

	
  


	  	
Name:


	  	
Title:












________________________________________________________


DTC Basic Subscription Confirmation Number(s)
[Federal Register Volume 60, Number 74 (Tuesday, April 18, 1995)]
[Notices]
[Page 19412]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-9486]



-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE
Drug Enforcement Administration


Alvin E. French, M.D.; Revocation of Registration

    On February 7, 1994, the Deputy Assistant Administrator, Office of 
Diversion Control, Drug Enforcement Administration (DEA), issued an 
Order to Show Cause to Alvin E. French, M.D., of Lima, New York. The 
Order to Show Cause sought to revoke Dr. French's DEA Certificate of 
Registration, AF6392106, and to deny any pending applications for 
renewal of such registration.
    The Order to Show Cause was sent to Dr. French at his registered 
location, 7304 East Main Street, Box 304, Lima, New York 14485, by 
registered mail. The Order to Show Cause was returned to DEA unclaimed 
with a notation on the envelope indicating that the forwarding order 
had expired. DEA investigators contacted the United States Post Office 
in Lima as well as the New York State Department of Health in an 
unsuccessful attempt to obtain a current address for Dr. French. Due to 
the fact that Dr. French has left no forwarding address, he is deemed 
to have waived his opportunity for a hearing. The Deputy Administrator 
now enters his final order in this matter without a hearing and based 
on the investigative file. See 21 CFR 1301.54(d) and 1301.57.
    The Order to Show Cause alleged that Dr. French's DEA registration 
should be revoked in light of the fact that he is no longer authorized 
by the State of New York to handle controlled substances. See 21 U.S.C. 
824(a)(3). The investigative file reveals that Dr. French voluntarily 
surrendered his New York State medical license effective November 5, 
1992.
    It is well established that the DEA cannot register a practitioner 
who is not duly authorized to handle controlled substances in the state 
in which he does business. See 21 U.S.C. 823(f). The DEA has 
consistently held that practitioners who lack state authorization to 
handle controlled substances cannot be registered by DEA. See Ramon 
Pla, M.D., 51 FR 41168 (1986); George S. Heath, M.D., 51 FR 26610 
(1986); Dale D. Shahan, D.D.S., 51 FR 23481 (1986).
    Consequently, the Deputy Administrator concludes that since Dr. 
French is no longer authorized to handle controlled substances by the 
State of New York, Dr. French's DEA Certificate of Registration should 
be revoked. Accordingly, the Deputy Administrator of the Drug 
Enforcement Administration, pursuant to the authority vested in him by 
21 U.S.C. 823 and 824 and 28 CFR 0.100(b) and 0.104, hereby orders that 
DEA Certificate of Registration, AF6392106, issued to Alvin E. French, 
M.D., be, and it hereby is, revoked, and that any pending applications 
for registration be, and they hereby are, denied. This order is 
effective May 18, 1995.

    Dated: April 12, 1995.
Stephen H. Greene,
Deputy Administrator.
[FR Doc. 95-9486 Filed 4-17-95; 8:45 am]
BILLING CODE 4410-09-M
extenathree.htm


Exhibit 10(A)(3)



























As of July 2, 2009







Nicholas D. Trbovich, Jr.


28 Tanglewood Drive, West


Orchard Park, NY 14127







Dear Mr. Nicholas D. Trbovich, Jr.:







You and Servotronics, Inc. (the “Company”) are parties to an Amended Employment Agreement, dated July 1, 2005 and ratified on June 30, 2006 pursuant to which you are employed by the Company.  This letter confirms such Amended Employment Agreement and subsequent ratification and subsequent Amendments dated August 4, 2006, July 6, 2007, July 9, 2008 and December 31, 2008 and any and all other relevant amendments (the “Amended Agreement”).







This letter will also confirm your agreement and that of the Company (pursuant to a resolution of the Board of Directors passed at a meeting held on July 2, 2009) to amend Paragraph 3 of the Amended Agreement to delete “$275,000” and insert in its place “$288,750.00” (effective May 1, 2009) subject to your acceptance which will be indicated by your signature below.







If the foregoing meets with your approval and you are willing to become bound hereby, will you please sign and return to the undersigned the enclosed copy of this letter.







Very truly yours,







SERVOTRONICS, INC.







	 	 	 	 	 
	
/s/ Bernadine E. Kucinski

	 	 	
 

	 
	
Bernadine E. Kucinski,

	 	 	
 

	 
	


Assistant Corporate Secretary.



	 	 	
 

	 











ACCEPTED AND AGREED












	 	 	 	 	 
	
/s/ Nicholas D. Trbovich, Jr.

	 	 	
As of July 2, 2009

	 
	
Nicholas D. Trbovich, Jr.

	 	 	
Date
EXHIBIT 31.1

                            SECTION 302 CERTIFICATION


I, Cecil Morris, certify that:

1.   I have reviewed this annual report on Form 10-KSB of LEGALPLAY
     ENTERTAINMENT INC.;

2.   Based on my knowledge, this annual report does not contain any untrue
     statement of a material fact or omit to state a material fact necessary to
     make the statements made, in light of the circumstances under which such
     statements were made, not misleading with respect to the period covered by
     this annual report;

3.   Based on my knowledge, the financial statement, and other financial
     information included in this annual report, fairly present in all material
     respects the financial condition, results of operations and cash flows of
     the registrant as of, and for, the periods presented in this annual report;

4.   The registrant's other certifying officers and I are responsible for
     establishing and maintaining disclosure controls and procedures (as defined
     in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

     (a)  designed such disclosure controls and procedures to ensure that
          material information relating to the registrant, including its
          consolidated subsidiaries, is made known to us by others within those
          entities, particularly during the period in which the annual report is
          being prepared;

     (b)  evaluated the effectiveness of the registrant's disclosure controls
          and procedures as of a date within 90 days prior to the filing date of
          this annual report (the "Evaluation Date"); and

     (c)  presented in this annual report our conclusions about the
          effectiveness of the disclosure controls and procedures based on our
          evaluation of the Evaluation Date;

5.   The registrant's other certifying officers and I have disclosed, based on
     our most recent evaluation, to the registrant's auditors and the audit
     committee of registrant's board of directors (or persons performing the
     equivalent function):

     (a)  all significant deficiencies in the design or operation of internal
          controls which could adversely affect the registrant's ability to
          record, process, summarize and report financial data and have
          identified for the registrant's auditors any material weakness in
          internal controls; and

     (b)  any fraud, whether or not material, that involves management or other
          employees who have a significant role in the registrant's internal
          controls; and

The registrant's other certifying officers and I have indicated in this annual
report whether there were significant changes in internal controls or in other
factors that could significantly affect internal controls subsequent to the date
of our most recent evaluation, including any corrective actions with regard to
significant deficiencies and material weaknesses.


/s/ Cecil Morris                             Date: August 29, 2005
-----------------------------------
Cecil Morris
Director, President / Secretary